Role of Dietary Supplements in the Management of Parkinson's Disease

被引:57
作者
Ciulla, Michele [1 ]
Marinelli, Lisa [1 ]
Cacciatore, Ivana [1 ]
Di Stefano, Antonio [1 ]
机构
[1] Univ G dAnnunzio, Dept Pharm, I-66100 Chieti, CH, Italy
关键词
Parkinson's disease; food supplements; functional food; antioxidants; anti-inflammatory; neuroprotection; natural compounds; PROTECTS DOPAMINERGIC-NEURONS; FOOD-FREQUENCY QUESTIONNAIRE; GINKGO-BILOBA EXTRACT; LIPOIC ACID PROTECTS; MONOAMINE-OXIDASE-B; COENZYME Q(10); ALPHA-SYNUCLEIN; RAT MODEL; VITAMIN-E; OXIDATIVE STRESS;
D O I
10.3390/biom9070271
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of food supplements or functional food has significantly increased in the past decades, especially to compensate both the modern lifestyle and the food shortages of the industrialized countries. Despite food supplements are habitually intended to correct nutritional deficiencies or to support specific physiological functions, they are often combined with common drug therapies to improve the patient's health and/or mitigate the symptoms of many chronic diseases such as cardiovascular diseases, cystic fibrosis, cancer, liver and gastrointestinal diseases. In recent years, increased attentions are given to the patient's diet, and the use of food supplements and functional food rich in vitamins and antioxidants plays a very important role in the treatment and prevention of neurodegenerative diseases such as Parkinson's disease (PD). Natural compounds, phytochemicals, vitamins, and minerals can prevent, delay, or alleviate the clinical symptoms of PD in contrast to some of the main physiopathological mechanisms involved in the development of the disease, like oxidative stress, free radical formation, and neuroinflammation. The purpose of this review is to collect scientific evidences which support the use of specific biomolecules and biogenic elements commonly found in food supplements or functional food to improve the clinical framework of patients with PD.
引用
收藏
页数:23
相关论文
共 134 条
[1]   N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why [J].
Aldini, Giancarlo ;
Altomare, Alessandra ;
Baron, Giovanna ;
Vistoli, Giulio ;
Carini, Marina ;
Borsani, Luisa ;
Sergio, Francesco .
FREE RADICAL RESEARCH, 2018, 52 (07) :751-762
[2]   Niacin improved rigidity and bradykinesia in a Parkinson's disease patient but also caused unacceptable nightmares and skin rash - A case report [J].
Alisky, JM .
NUTRITIONAL NEUROSCIENCE, 2005, 8 (5-6) :327-329
[3]   Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism [J].
Anderson, D. W. ;
Bradbury, K. A. ;
Schneider, J. S. .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 28 (03) :610-617
[4]   Protective effect of melatonin in a chronic experimental model of Parkinson's disease [J].
Antolín, I ;
Mayo, JC ;
Sainz, RM ;
del Brío, MD ;
Herrera, F ;
Martín, V ;
Rodríguez, C .
BRAIN RESEARCH, 2002, 943 (02) :163-173
[5]   Extraction and determination of bioactive compounds from bee pollen [J].
Ares, Ana M. ;
Valverde, Silvia ;
Bernal, Jose L. ;
Nozal, Maria J. ;
Bernal, Jose .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 147 :110-124
[6]   Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases [J].
Banaclocha, MM .
MEDICAL HYPOTHESES, 2001, 56 (04) :472-477
[7]  
Baser KHC, 2008, CURR PHARM DESIGN, V14, P3106, DOI 10.2174/138161208786404227
[8]   Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged [J].
Beal, MF ;
Matthews, RT ;
Tieleman, A ;
Shults, CW .
BRAIN RESEARCH, 1998, 783 (01) :109-114
[9]  
Beitz Janice M, 2014, Front Biosci (Schol Ed), V6, P65
[10]   Creatine supplementation in Parkinson disease:: A placebo-controlled randomized pilot trial [J].
Bender, A. ;
Koch, W. ;
Elstner, M. ;
Schombacher, Y. ;
Bender, J. ;
Moeschl, M. ;
Gekeler, F. ;
Mueller-Myhsok, B. ;
Gasser, T. ;
Tatsch, K. ;
Klopstock, T. .
NEUROLOGY, 2006, 67 (07) :1262-1264